TY - JOUR
T1 - Amnioexchange for fetuses with gastroschisis
T2 - is it effective?
AU - Midrio, Paola
AU - Stefanutti, Giorgio
AU - Mussap, Michele
AU - D'Antona, Donato
AU - Zolpi, Elisa
AU - Gamba, Piergiorgio
PY - 2007/7
Y1 - 2007/7
N2 - Background/Purpose: Amniotic fluid of fetuses with gastroschisis (GS) contains inflammatory mediators, gastrointestinal, and urinary waste products. Dilution and removal of such harmful substances have been advocated to prevent damage to the herniated intestine. We evaluated the effectiveness of serial amnioexchange procedures in 8 consecutive fetuses with GS. Methods: Amnioexchange was performed bimonthly during the third trimester. Amniotic fluid collected before each procedure was tested for pH, osmolarity, urea, creatinine, cystatin-C, proteins, albumin, bilirubin, biliary salts, pancreatic amylase, serum amyloid A, C-reactive protein, alanine transaminase (ALT), alcaline phosphatase (ALP), gamma-glutamyl transpetidase (γGT), tumor necrosis factor α, interleukin 2, interleukin 6, epidermal growth factor, transforming growth factor β, and myeloperoxidase. Results: A total of 25 samples (median, 3 per fetus) were examined. Biochemical or inflammatory markers did not correlate with gestational age, nor was any trend observed in values from individual patients during the course of amnioexchange treatment. There was no correlation between biochemical or inflammatory markers and clinical outcome, including time to full enteral feeding. Conclusions: Serial amnioexchanges did not modify the biochemical or inflammatory status of amniotic fluid nor appeared to prevent injury to the herniated gut. Because repeated amnioexchanges may carry some risks, their use in fetuses with GS is not recommended outside the setting of a prospective randomized trial.
AB - Background/Purpose: Amniotic fluid of fetuses with gastroschisis (GS) contains inflammatory mediators, gastrointestinal, and urinary waste products. Dilution and removal of such harmful substances have been advocated to prevent damage to the herniated intestine. We evaluated the effectiveness of serial amnioexchange procedures in 8 consecutive fetuses with GS. Methods: Amnioexchange was performed bimonthly during the third trimester. Amniotic fluid collected before each procedure was tested for pH, osmolarity, urea, creatinine, cystatin-C, proteins, albumin, bilirubin, biliary salts, pancreatic amylase, serum amyloid A, C-reactive protein, alanine transaminase (ALT), alcaline phosphatase (ALP), gamma-glutamyl transpetidase (γGT), tumor necrosis factor α, interleukin 2, interleukin 6, epidermal growth factor, transforming growth factor β, and myeloperoxidase. Results: A total of 25 samples (median, 3 per fetus) were examined. Biochemical or inflammatory markers did not correlate with gestational age, nor was any trend observed in values from individual patients during the course of amnioexchange treatment. There was no correlation between biochemical or inflammatory markers and clinical outcome, including time to full enteral feeding. Conclusions: Serial amnioexchanges did not modify the biochemical or inflammatory status of amniotic fluid nor appeared to prevent injury to the herniated gut. Because repeated amnioexchanges may carry some risks, their use in fetuses with GS is not recommended outside the setting of a prospective randomized trial.
KW - Amnioexchange
KW - Amnioinfusion
KW - Gastroschisis
KW - Inflammatory mediators
UR - http://www.scopus.com/inward/record.url?scp=34248152056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248152056&partnerID=8YFLogxK
U2 - 10.1016/j.jpedsurg.2006.12.029
DO - 10.1016/j.jpedsurg.2006.12.029
M3 - Article
C2 - 17502182
AN - SCOPUS:34248152056
VL - 42
SP - 777
EP - 782
JO - Journal of Pediatric Surgery
JF - Journal of Pediatric Surgery
SN - 0022-3468
IS - 5
ER -